个人中心 - 老虎社区

HoSei

IP属地：未知

帖子 · 27帖子 · 27
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- HoSeiHoSei
  ·2021-11-29
  The new COVID-19 variant is bad news for the rest of the markets…
  Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week
  The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday
  Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week
  1,071 评论
  4
  分享
  举报
- HoSeiHoSei
  ·2021-11-28
  Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.
  非常抱歉，此主贴已删除
  1,270 评论
  2
  分享
  举报
- HoSeiHoSei
  ·2021-11-12
  It is still a great buy for me at $22-24
  Analysts Adjust Palantir Price Targets Post Q3 Results
  Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat. RBC Ca
  Analysts Adjust Palantir Price Targets Post Q3 Results
  1,095 评论
  点赞
  分享
  举报
- HoSeiHoSei
  ·2021-11-10
  $24 range is a Great buy
  Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y
  Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended
  Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y
  1,357 评论
  3
  分享
  举报
- HoSeiHoSei
  ·2021-11-09
  $Palantir Technologies Inc.(PLTR)$Pay day!
  1,269 评论
  1
  分享
  举报
- HoSeiHoSei
  ·2021-11-09
  $Pinterest, Inc.(PINS)$Share share
  892 评论
  点赞
  分享
  举报
- HoSeiHoSei
  ·2021-11-06
  $Pinterest, Inc.(PINS)$Share
  1,023 评论
  点赞
  分享
  举报
- HoSeiHoSei
  ·2021-11-05
  $Palantir Technologies Inc.(PLTR)$Share
  1,111 评论
  1
  分享
  举报
- HoSeiHoSei
  ·2021-11-05
  $Pinterest, Inc.(PINS)$Too good to miss
  1,203 评论
  1
  分享
  举报
- HoSeiHoSei
  ·2021-11-04
  $Palantir Technologies Inc.(PLTR)$To the moon tonight
  946 评论
  2
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3579647754039667","uuid":"3579647754039667","gmtCreate":1616554047033,"gmtModify":1617250465419,"name":"HoSei","pinyin":"hosei","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":110,"tweetSize":27,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.01","exceedPercentage":"93.00%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":600561028,"gmtCreate":1638175738678,"gmtModify":1638175771458,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"The new COVID-19&nbsp;variant is bad news&nbsp;for the rest of the markets…","listText":"The new COVID-19&nbsp;variant is bad news&nbsp;for the rest of the markets…","text":"The new COVID-19 variant is bad news for the rest of the markets…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600561028","repostId":"1119853738","repostType":4,"repost":{"id":"1119853738","kind":"news","pubTimestamp":1638153494,"share":"https://www.laohu8.com/m/news/1119853738?lang=&edition=full","pubTime":"2021-11-29 10:38","market":"us","language":"en","title":"Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1119853738","media":"Motley Fool","summary":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday","content":"<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.</p>\n<p>While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.</p>\n<p>How should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers&nbsp;<b>Moderna</b>(NASDAQ:MRNA),<b>Pfizer</b>(NYSE:PFE), and&nbsp;<b>Novavax</b>(NASDAQ:NVAX)&nbsp;all&nbsp;vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.</p>\n<p>The pandemic's latest twist makes these three stocks screaming buys</p>\n<p>Moderna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.</p>\n<p>Pfizer, for its part, said that its&nbsp;<b>BioNTech</b>-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.</p>\n<p>Why are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.</p>\n<p>While Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.</p>\n<p>On the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have&nbsp;dipped in the back half of 2021&nbsp;in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.</p>\n<p>What's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.</p>\n<p>In short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer, and Novavax Are Must-Own Stocks This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119853738","content_text":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.\nWhile there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.\nHow should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers Moderna(NASDAQ:MRNA),Pfizer(NYSE:PFE), and Novavax(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.\nThe pandemic's latest twist makes these three stocks screaming buys\nModerna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.\nPfizer, for its part, said that its BioNTech-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.\nWhy are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.\nWhile Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.\nOn the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.\nWhat's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.\nIn short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600964410,"gmtCreate":1638056677188,"gmtModify":1638063470923,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.","listText":"Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.","text":"Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600964410","repostId":"1113757092","repostType":4,"isVote":1,"tweetType":1,"viewCount":1270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879035089,"gmtCreate":1636669247252,"gmtModify":1636669247382,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"It is still&nbsp;a great&nbsp;buy for me at $22-24","listText":"It is still&nbsp;a great&nbsp;buy for me at $22-24","text":"It is still a great buy for me at $22-24","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879035089","repostId":"1139881214","repostType":2,"repost":{"id":"1139881214","kind":"news","pubTimestamp":1636619165,"share":"https://www.laohu8.com/m/news/1139881214?lang=&edition=full","pubTime":"2021-11-11 16:26","market":"us","language":"en","title":"Analysts Adjust Palantir Price Targets Post Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1139881214","media":"Benzinga","summary":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Ca","content":"<p></p>\n<ul>\n <li><p>Few analysts slashed price targets on<b>Palantir Technologies Inc</b>(NYSE:PLTR)despite the Q3 beat.</p></li>\n <li><p><b>RBC Capital</b>analyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.</p></li>\n <li><p>The analyst cites the company's \"mixed\" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is \"unsustainable.\"</p></li>\n <li><p>Jaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as \"full.\"</p></li>\n <li><p><b>William Blair</b>&nbsp;analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.</p></li>\n <li><p>While Palantir delivered \"strong\" headline numbers, the growth in the second half of 2021 is \"heavily reliant on strategic investments.\"</p></li>\n <li><p>The analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.</p></li>\n <li><p><b>Citi</b>&nbsp;analyst Tyler Radke states Palantir's decelerating growth \"came into center view\" in Q3 with weakness in both commercial and government.</p></li>\n <li><p>While guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.</p></li>\n <li><p>He reiterates a Sell rating on the shares with an $18 price target.</p></li>\n <li><p><b>Wolfe Research</b>&nbsp;analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an \"interesting\" Q3 report.</p></li>\n <li><p>He notes that shares were down after the announcement, which he blames a \"meaningful top-line deceleration,\" pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.</p></li>\n <li><p>His lower price target is due to the core growth deceleration as he is \"not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue.\"</p></li>\n <li><p><b>Morgan Stanley</b>&nbsp;analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.</p></li>\n <li><p>He reiterated an Underweight after delivering another beat versus consensus expectations \"across all key headline metrics\" in Q3.</p></li>\n <li><p>Weiss sees \"signs of slowing underneath the hood\" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.</p></li>\n <li><p><b>Price Action:</b>PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.</p></li>\n</ul>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Analysts Adjust Palantir Price Targets Post Q3 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnalysts Adjust Palantir Price Targets Post Q3 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139881214","content_text":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.\nThe analyst cites the company's \"mixed\" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is \"unsustainable.\"\nJaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as \"full.\"\nWilliam Blair analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.\nWhile Palantir delivered \"strong\" headline numbers, the growth in the second half of 2021 is \"heavily reliant on strategic investments.\"\nThe analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.\nCiti analyst Tyler Radke states Palantir's decelerating growth \"came into center view\" in Q3 with weakness in both commercial and government.\nWhile guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.\nHe reiterates a Sell rating on the shares with an $18 price target.\nWolfe Research analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an \"interesting\" Q3 report.\nHe notes that shares were down after the announcement, which he blames a \"meaningful top-line deceleration,\" pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.\nHis lower price target is due to the core growth deceleration as he is \"not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue.\"\nMorgan Stanley analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.\nHe reiterated an Underweight after delivering another beat versus consensus expectations \"across all key headline metrics\" in Q3.\nWeiss sees \"signs of slowing underneath the hood\" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.\nPrice Action:PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1095,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847242787,"gmtCreate":1636529421946,"gmtModify":1636529422091,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"$24 range is a&nbsp;Great buy","listText":"$24 range is a&nbsp;Great buy","text":"$24 range is a Great buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847242787","repostId":"1105674649","repostType":2,"repost":{"id":"1105674649","kind":"news","pubTimestamp":1636459675,"share":"https://www.laohu8.com/m/news/1105674649?lang=&edition=full","pubTime":"2021-11-09 20:07","market":"us","language":"en","title":"Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=1105674649","media":"businesswire","summary":"Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended","content":"<p>Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.</p>\n<p><b>Q3 2021 Highlights</b></p>\n<ul>\n <li>Total revenue grew 36% year-over-year to $392 million</li>\n <li>Added 34 net new customers in Q3</li>\n <li>Commercial customer count grew 46% quarter-over-quarter</li>\n <li>US commercial revenue grew 103% year-over-year</li>\n <li>Cash flow from operations of $101 million, representing a 26% margin</li>\n <li>Adjusted free cash flow of $119 million, representing a 30% margin</li>\n <li>Closed 54 deals of $1 million or more, of which:</li>\n <li>Total remaining deal value grew 50% year-over-year to $3.6 billion</li>\n <li>GAAP net loss per share, diluted of $(0.05)</li>\n <li>Adjusted earnings per share, diluted of $0.04</li>\n</ul>\n<p><b>Q1-Q3 2021 Highlights</b></p>\n<ul>\n <li>Total revenue grew 44% year-over-year to $1.1 billion</li>\n <li>Commercial customer count increased 135% since December 31, 2020</li>\n <li>Cash flow from operations of $240 million, representing a 22% margin</li>\n <li>Adjusted free cash flow of $320 million, representing a 29% margin</li>\n</ul>\n<p><b>Q3 2021 Financial Summary</b></p>\n<p><img src=\"https://static.tigerbbs.com/658b280b0509d4e5fe970e5de61570e5\" tg-width=\"985\" tg-height=\"494\" referrerpolicy=\"no-referrer\"></p>\n<table>\n <tbody>\n  <tr></tr>\n  <tr></tr>\n </tbody>\n</table>\n<p><b>Outlook</b></p>\n<p>For Q4 2021, we expect:</p>\n<ul>\n <li>$418 million in revenue.</li>\n <li>Adjusted operating margin of 22%.</li>\n</ul>\n<p>For full year 2021:</p>\n<ul>\n <li>We expect revenue growth of 40% to $1.527 billion.</li>\n <li>We are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.</li>\n</ul>\n<p>Per long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:</p>\n<ul>\n <li>Annual revenue growth of 30% or greater for 2021 through 2025.</li>\n</ul>\n<p>Palantir&nbsp;shares&nbsp;once&nbsp;rose&nbsp;nearly&nbsp;5%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/ca256a464d04c12064d041bcfbdf1049\" tg-width=\"894\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1584686423112","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-09 20:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesswire.com/news/home/20211109005487/en/Palantir-Expects-40-Revenue-Growth-in-FY-2021-Q3-US-Commercial-Revenue-up-103-YY><strong>businesswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.\nQ3 2021 Highlights\n\nTotal revenue grew 36% year-over-year to $392 million\nAdded...</p>\n\n<a href=\"https://www.businesswire.com/news/home/20211109005487/en/Palantir-Expects-40-Revenue-Growth-in-FY-2021-Q3-US-Commercial-Revenue-up-103-YY\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.businesswire.com/news/home/20211109005487/en/Palantir-Expects-40-Revenue-Growth-in-FY-2021-Q3-US-Commercial-Revenue-up-103-YY","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105674649","content_text":"Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.\nQ3 2021 Highlights\n\nTotal revenue grew 36% year-over-year to $392 million\nAdded 34 net new customers in Q3\nCommercial customer count grew 46% quarter-over-quarter\nUS commercial revenue grew 103% year-over-year\nCash flow from operations of $101 million, representing a 26% margin\nAdjusted free cash flow of $119 million, representing a 30% margin\nClosed 54 deals of $1 million or more, of which:\nTotal remaining deal value grew 50% year-over-year to $3.6 billion\nGAAP net loss per share, diluted of $(0.05)\nAdjusted earnings per share, diluted of $0.04\n\nQ1-Q3 2021 Highlights\n\nTotal revenue grew 44% year-over-year to $1.1 billion\nCommercial customer count increased 135% since December 31, 2020\nCash flow from operations of $240 million, representing a 22% margin\nAdjusted free cash flow of $320 million, representing a 29% margin\n\nQ3 2021 Financial Summary\n\n\n\n\n\n\n\nOutlook\nFor Q4 2021, we expect:\n\n$418 million in revenue.\nAdjusted operating margin of 22%.\n\nFor full year 2021:\n\nWe expect revenue growth of 40% to $1.527 billion.\nWe are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.\n\nPer long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:\n\nAnnual revenue growth of 30% or greater for 2021 through 2025.\n\nPalantir shares once rose nearly 5% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844412695,"gmtCreate":1636451155235,"gmtModify":1636455795644,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Pay day!","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Pay day!","text":"$Palantir Technologies Inc.(PLTR)$Pay day!","images":[{"img":"https://static.tigerbbs.com/39f5d602b05e634df1b378548a609fb0","width":"750","height":"2567"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844412695","isVote":1,"tweetType":1,"viewCount":1269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844341062,"gmtCreate":1636396890468,"gmtModify":1636396890638,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share share","listText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share share","text":"$Pinterest, Inc.(PINS)$Share share","images":[{"img":"https://static.tigerbbs.com/9c182b95564d66208c97e2677672c2fc","width":"750","height":"2557"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844341062","isVote":1,"tweetType":1,"viewCount":892,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842281805,"gmtCreate":1636181663868,"gmtModify":1636181664021,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share&nbsp;","listText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share&nbsp;","text":"$Pinterest, Inc.(PINS)$Share","images":[{"img":"https://static.tigerbbs.com/0814ceec8bf114ea928080df8fe5a29a","width":"750","height":"2747"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842281805","isVote":1,"tweetType":1,"viewCount":1023,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846793967,"gmtCreate":1636111442688,"gmtModify":1636111442785,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Share","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Share","text":"$Palantir Technologies Inc.(PLTR)$Share","images":[{"img":"https://static.tigerbbs.com/df82625bccca4b69cc0d7b8db8e2e937","width":"750","height":"2747"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846793967","isVote":1,"tweetType":1,"viewCount":1111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846790678,"gmtCreate":1636111208772,"gmtModify":1636111208918,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Too good to miss","listText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Too good to miss","text":"$Pinterest, Inc.(PINS)$Too good to miss","images":[{"img":"https://static.tigerbbs.com/103cc76613c65f459e05d5c41be26f9c","width":"750","height":"1464"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846790678","isVote":1,"tweetType":1,"viewCount":1203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":848811455,"gmtCreate":1635988498720,"gmtModify":1635988498831,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>To the moon tonight&nbsp;","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>To the moon tonight&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$To the moon tonight","images":[{"img":"https://static.tigerbbs.com/f3428097887558839f6c9a8958c06aae","width":"750","height":"1464"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848811455","isVote":1,"tweetType":1,"viewCount":946,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}